[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Remdesivir (COVID-19) Market Research Report 2024(Status and Outlook)

April 2024 | 117 pages | ID: G95ADD6BCCA4EN
Bosson Research

US$ 2,800.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Report Overview

This report provides a deep insight into the global Remdesivir (COVID-19) market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Remdesivir (COVID-19) Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Remdesivir (COVID-19) market in any manner.

Global Remdesivir (COVID-19) Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

Gilead Sciences

Bright Gene

Hainan Haiyao

Kelun Pharma

Hunan Warrant Pharmaceutical

Borui Bio-Pharmaceutical

Berry Global Group

Inovio Pharmaceuticals

Market Segmentation (by Type)

5mg

10mg

50mg

100mg

Market Segmentation (by Application)

Hospital

Clinics

Drug Store

Others

Geographic Segmentation
  • North America (USA, Canada, Mexico)
  • Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
  • Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
  • South America (Brazil, Argentina, Columbia, Rest of South America)
  • The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
  • Industry drivers, restraints, and opportunities covered in the study
  • Neutral perspective on the market performance
  • Recent industry trends and developments
  • Competitive landscape & strategies of key players
  • Potential & niche segments and regions exhibiting promising growth covered
  • Historical, current, and projected market size, in terms of value
  • In-depth analysis of the Remdesivir (COVID-19) Market
  • Overview of the regional outlook of the Remdesivir (COVID-19) Market:
Key Reasons to Buy this Report:
  • Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
  • This enables you to anticipate market changes to remain ahead of your competitors
  • You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
  • The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
  • Provision of market value (USD Billion) data for each segment and sub-segment
  • Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
  • Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
  • Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
  • Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
  • The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
  • Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
  • Provides insight into the market through Value Chain
  • Market dynamics scenario, along with growth opportunities of the market in the years to come
  • 6-month post-sales analyst support
Customization of the Report

In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.

Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Remdesivir (COVID-19) Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.

Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE

1.1 Market Definition and Statistical Scope of Remdesivir (COVID-19)
1.2 Key Market Segments
  1.2.1 Remdesivir (COVID-19) Segment by Type
  1.2.2 Remdesivir (COVID-19) Segment by Application
1.3 Methodology & Sources of Information
  1.3.1 Research Methodology
  1.3.2 Research Process
  1.3.3 Market Breakdown and Data Triangulation
  1.3.4 Base Year
  1.3.5 Report Assumptions & Caveats

2 REMDESIVIR (COVID-19) MARKET OVERVIEW

2.1 Global Market Overview
  2.1.1 Global Remdesivir (COVID-19) Market Size (M USD) Estimates and Forecasts (2019-2030)
  2.1.2 Global Remdesivir (COVID-19) Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region

3 REMDESIVIR (COVID-19) MARKET COMPETITIVE LANDSCAPE

3.1 Global Remdesivir (COVID-19) Sales by Manufacturers (2019-2024)
3.2 Global Remdesivir (COVID-19) Revenue Market Share by Manufacturers (2019-2024)
3.3 Remdesivir (COVID-19) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Remdesivir (COVID-19) Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Remdesivir (COVID-19) Sales Sites, Area Served, Product Type
3.6 Remdesivir (COVID-19) Market Competitive Situation and Trends
  3.6.1 Remdesivir (COVID-19) Market Concentration Rate
  3.6.2 Global 5 and 10 Largest Remdesivir (COVID-19) Players Market Share by Revenue
  3.6.3 Mergers & Acquisitions, Expansion

4 REMDESIVIR (COVID-19) INDUSTRY CHAIN ANALYSIS

4.1 Remdesivir (COVID-19) Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis

5 THE DEVELOPMENT AND DYNAMICS OF REMDESIVIR (COVID-19) MARKET

5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
  5.5.1 New Product Developments
  5.5.2 Mergers & Acquisitions
  5.5.3 Expansions
  5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies

6 REMDESIVIR (COVID-19) MARKET SEGMENTATION BY TYPE

6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Remdesivir (COVID-19) Sales Market Share by Type (2019-2024)
6.3 Global Remdesivir (COVID-19) Market Size Market Share by Type (2019-2024)
6.4 Global Remdesivir (COVID-19) Price by Type (2019-2024)

7 REMDESIVIR (COVID-19) MARKET SEGMENTATION BY APPLICATION

7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Remdesivir (COVID-19) Market Sales by Application (2019-2024)
7.3 Global Remdesivir (COVID-19) Market Size (M USD) by Application (2019-2024)
7.4 Global Remdesivir (COVID-19) Sales Growth Rate by Application (2019-2024)

8 REMDESIVIR (COVID-19) MARKET SEGMENTATION BY REGION

8.1 Global Remdesivir (COVID-19) Sales by Region
  8.1.1 Global Remdesivir (COVID-19) Sales by Region
  8.1.2 Global Remdesivir (COVID-19) Sales Market Share by Region
8.2 North America
  8.2.1 North America Remdesivir (COVID-19) Sales by Country
  8.2.2 U.S.
  8.2.3 Canada
  8.2.4 Mexico
8.3 Europe
  8.3.1 Europe Remdesivir (COVID-19) Sales by Country
  8.3.2 Germany
  8.3.3 France
  8.3.4 U.K.
  8.3.5 Italy
  8.3.6 Russia
8.4 Asia Pacific
  8.4.1 Asia Pacific Remdesivir (COVID-19) Sales by Region
  8.4.2 China
  8.4.3 Japan
  8.4.4 South Korea
  8.4.5 India
  8.4.6 Southeast Asia
8.5 South America
  8.5.1 South America Remdesivir (COVID-19) Sales by Country
  8.5.2 Brazil
  8.5.3 Argentina
  8.5.4 Columbia
8.6 Middle East and Africa
  8.6.1 Middle East and Africa Remdesivir (COVID-19) Sales by Region
  8.6.2 Saudi Arabia
  8.6.3 UAE
  8.6.4 Egypt
  8.6.5 Nigeria
  8.6.6 South Africa

9 KEY COMPANIES PROFILE

9.1 Gilead Sciences
  9.1.1 Gilead Sciences Remdesivir (COVID-19) Basic Information
  9.1.2 Gilead Sciences Remdesivir (COVID-19) Product Overview
  9.1.3 Gilead Sciences Remdesivir (COVID-19) Product Market Performance
  9.1.4 Gilead Sciences Business Overview
  9.1.5 Gilead Sciences Remdesivir (COVID-19) SWOT Analysis
  9.1.6 Gilead Sciences Recent Developments
9.2 Bright Gene
  9.2.1 Bright Gene Remdesivir (COVID-19) Basic Information
  9.2.2 Bright Gene Remdesivir (COVID-19) Product Overview
  9.2.3 Bright Gene Remdesivir (COVID-19) Product Market Performance
  9.2.4 Bright Gene Business Overview
  9.2.5 Bright Gene Remdesivir (COVID-19) SWOT Analysis
  9.2.6 Bright Gene Recent Developments
9.3 Hainan Haiyao
  9.3.1 Hainan Haiyao Remdesivir (COVID-19) Basic Information
  9.3.2 Hainan Haiyao Remdesivir (COVID-19) Product Overview
  9.3.3 Hainan Haiyao Remdesivir (COVID-19) Product Market Performance
  9.3.4 Hainan Haiyao Remdesivir (COVID-19) SWOT Analysis
  9.3.5 Hainan Haiyao Business Overview
  9.3.6 Hainan Haiyao Recent Developments
9.4 Kelun Pharma
  9.4.1 Kelun Pharma Remdesivir (COVID-19) Basic Information
  9.4.2 Kelun Pharma Remdesivir (COVID-19) Product Overview
  9.4.3 Kelun Pharma Remdesivir (COVID-19) Product Market Performance
  9.4.4 Kelun Pharma Business Overview
  9.4.5 Kelun Pharma Recent Developments
9.5 Hunan Warrant Pharmaceutical
  9.5.1 Hunan Warrant Pharmaceutical Remdesivir (COVID-19) Basic Information
  9.5.2 Hunan Warrant Pharmaceutical Remdesivir (COVID-19) Product Overview
  9.5.3 Hunan Warrant Pharmaceutical Remdesivir (COVID-19) Product Market Performance
  9.5.4 Hunan Warrant Pharmaceutical Business Overview
  9.5.5 Hunan Warrant Pharmaceutical Recent Developments
9.6 Borui Bio-Pharmaceutical
  9.6.1 Borui Bio-Pharmaceutical Remdesivir (COVID-19) Basic Information
  9.6.2 Borui Bio-Pharmaceutical Remdesivir (COVID-19) Product Overview
  9.6.3 Borui Bio-Pharmaceutical Remdesivir (COVID-19) Product Market Performance
  9.6.4 Borui Bio-Pharmaceutical Business Overview
  9.6.5 Borui Bio-Pharmaceutical Recent Developments
9.7 Berry Global Group
  9.7.1 Berry Global Group Remdesivir (COVID-19) Basic Information
  9.7.2 Berry Global Group Remdesivir (COVID-19) Product Overview
  9.7.3 Berry Global Group Remdesivir (COVID-19) Product Market Performance
  9.7.4 Berry Global Group Business Overview
  9.7.5 Berry Global Group Recent Developments
9.8 Inovio Pharmaceuticals
  9.8.1 Inovio Pharmaceuticals Remdesivir (COVID-19) Basic Information
  9.8.2 Inovio Pharmaceuticals Remdesivir (COVID-19) Product Overview
  9.8.3 Inovio Pharmaceuticals Remdesivir (COVID-19) Product Market Performance
  9.8.4 Inovio Pharmaceuticals Business Overview
  9.8.5 Inovio Pharmaceuticals Recent Developments

10 REMDESIVIR (COVID-19) MARKET FORECAST BY REGION

10.1 Global Remdesivir (COVID-19) Market Size Forecast
10.2 Global Remdesivir (COVID-19) Market Forecast by Region
  10.2.1 North America Market Size Forecast by Country
  10.2.2 Europe Remdesivir (COVID-19) Market Size Forecast by Country
  10.2.3 Asia Pacific Remdesivir (COVID-19) Market Size Forecast by Region
  10.2.4 South America Remdesivir (COVID-19) Market Size Forecast by Country
  10.2.5 Middle East and Africa Forecasted Consumption of Remdesivir (COVID-19) by Country

11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)

11.1 Global Remdesivir (COVID-19) Market Forecast by Type (2025-2030)
  11.1.1 Global Forecasted Sales of Remdesivir (COVID-19) by Type (2025-2030)
  11.1.2 Global Remdesivir (COVID-19) Market Size Forecast by Type (2025-2030)
  11.1.3 Global Forecasted Price of Remdesivir (COVID-19) by Type (2025-2030)
11.2 Global Remdesivir (COVID-19) Market Forecast by Application (2025-2030)
  11.2.1 Global Remdesivir (COVID-19) Sales (Kilotons) Forecast by Application
  11.2.2 Global Remdesivir (COVID-19) Market Size (M USD) Forecast by Application (2025-2030)

12 CONCLUSION AND KEY FINDINGS

LIST OF TABLES

Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Remdesivir (COVID-19) Market Size Comparison by Region (M USD)
Table 5. Global Remdesivir (COVID-19) Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global Remdesivir (COVID-19) Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Remdesivir (COVID-19) Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Remdesivir (COVID-19) Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Remdesivir (COVID-19) as of 2022)
Table 10. Global Market Remdesivir (COVID-19) Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Remdesivir (COVID-19) Sales Sites and Area Served
Table 12. Manufacturers Remdesivir (COVID-19) Product Type
Table 13. Global Remdesivir (COVID-19) Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Remdesivir (COVID-19)
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Remdesivir (COVID-19) Market Challenges
Table 22. Global Remdesivir (COVID-19) Sales by Type (Kilotons)
Table 23. Global Remdesivir (COVID-19) Market Size by Type (M USD)
Table 24. Global Remdesivir (COVID-19) Sales (Kilotons) by Type (2019-2024)
Table 25. Global Remdesivir (COVID-19) Sales Market Share by Type (2019-2024)
Table 26. Global Remdesivir (COVID-19) Market Size (M USD) by Type (2019-2024)
Table 27. Global Remdesivir (COVID-19) Market Size Share by Type (2019-2024)
Table 28. Global Remdesivir (COVID-19) Price (USD/Ton) by Type (2019-2024)
Table 29. Global Remdesivir (COVID-19) Sales (Kilotons) by Application
Table 30. Global Remdesivir (COVID-19) Market Size by Application
Table 31. Global Remdesivir (COVID-19) Sales by Application (2019-2024) & (Kilotons)
Table 32. Global Remdesivir (COVID-19) Sales Market Share by Application (2019-2024)
Table 33. Global Remdesivir (COVID-19) Sales by Application (2019-2024) & (M USD)
Table 34. Global Remdesivir (COVID-19) Market Share by Application (2019-2024)
Table 35. Global Remdesivir (COVID-19) Sales Growth Rate by Application (2019-2024)
Table 36. Global Remdesivir (COVID-19) Sales by Region (2019-2024) & (Kilotons)
Table 37. Global Remdesivir (COVID-19) Sales Market Share by Region (2019-2024)
Table 38. North America Remdesivir (COVID-19) Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe Remdesivir (COVID-19) Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific Remdesivir (COVID-19) Sales by Region (2019-2024) & (Kilotons)
Table 41. South America Remdesivir (COVID-19) Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa Remdesivir (COVID-19) Sales by Region (2019-2024) & (Kilotons)
Table 43. Gilead Sciences Remdesivir (COVID-19) Basic Information
Table 44. Gilead Sciences Remdesivir (COVID-19) Product Overview
Table 45. Gilead Sciences Remdesivir (COVID-19) Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. Gilead Sciences Business Overview
Table 47. Gilead Sciences Remdesivir (COVID-19) SWOT Analysis
Table 48. Gilead Sciences Recent Developments
Table 49. Bright Gene Remdesivir (COVID-19) Basic Information
Table 50. Bright Gene Remdesivir (COVID-19) Product Overview
Table 51. Bright Gene Remdesivir (COVID-19) Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. Bright Gene Business Overview
Table 53. Bright Gene Remdesivir (COVID-19) SWOT Analysis
Table 54. Bright Gene Recent Developments
Table 55. Hainan Haiyao Remdesivir (COVID-19) Basic Information
Table 56. Hainan Haiyao Remdesivir (COVID-19) Product Overview
Table 57. Hainan Haiyao Remdesivir (COVID-19) Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. Hainan Haiyao Remdesivir (COVID-19) SWOT Analysis
Table 59. Hainan Haiyao Business Overview
Table 60. Hainan Haiyao Recent Developments
Table 61. Kelun Pharma Remdesivir (COVID-19) Basic Information
Table 62. Kelun Pharma Remdesivir (COVID-19) Product Overview
Table 63. Kelun Pharma Remdesivir (COVID-19) Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 64. Kelun Pharma Business Overview
Table 65. Kelun Pharma Recent Developments
Table 66. Hunan Warrant Pharmaceutical Remdesivir (COVID-19) Basic Information
Table 67. Hunan Warrant Pharmaceutical Remdesivir (COVID-19) Product Overview
Table 68. Hunan Warrant Pharmaceutical Remdesivir (COVID-19) Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 69. Hunan Warrant Pharmaceutical Business Overview
Table 70. Hunan Warrant Pharmaceutical Recent Developments
Table 71. Borui Bio-Pharmaceutical Remdesivir (COVID-19) Basic Information
Table 72. Borui Bio-Pharmaceutical Remdesivir (COVID-19) Product Overview
Table 73. Borui Bio-Pharmaceutical Remdesivir (COVID-19) Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 74. Borui Bio-Pharmaceutical Business Overview
Table 75. Borui Bio-Pharmaceutical Recent Developments
Table 76. Berry Global Group Remdesivir (COVID-19) Basic Information
Table 77. Berry Global Group Remdesivir (COVID-19) Product Overview
Table 78. Berry Global Group Remdesivir (COVID-19) Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 79. Berry Global Group Business Overview
Table 80. Berry Global Group Recent Developments
Table 81. Inovio Pharmaceuticals Remdesivir (COVID-19) Basic Information
Table 82. Inovio Pharmaceuticals Remdesivir (COVID-19) Product Overview
Table 83. Inovio Pharmaceuticals Remdesivir (COVID-19) Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 84. Inovio Pharmaceuticals Business Overview
Table 85. Inovio Pharmaceuticals Recent Developments
Table 86. Global Remdesivir (COVID-19) Sales Forecast by Region (2025-2030) & (Kilotons)
Table 87. Global Remdesivir (COVID-19) Market Size Forecast by Region (2025-2030) & (M USD)
Table 88. North America Remdesivir (COVID-19) Sales Forecast by Country (2025-2030) & (Kilotons)
Table 89. North America Remdesivir (COVID-19) Market Size Forecast by Country (2025-2030) & (M USD)
Table 90. Europe Remdesivir (COVID-19) Sales Forecast by Country (2025-2030) & (Kilotons)
Table 91. Europe Remdesivir (COVID-19) Market Size Forecast by Country (2025-2030) & (M USD)
Table 92. Asia Pacific Remdesivir (COVID-19) Sales Forecast by Region (2025-2030) & (Kilotons)
Table 93. Asia Pacific Remdesivir (COVID-19) Market Size Forecast by Region (2025-2030) & (M USD)
Table 94. South America Remdesivir (COVID-19) Sales Forecast by Country (2025-2030) & (Kilotons)
Table 95. South America Remdesivir (COVID-19) Market Size Forecast by Country (2025-2030) & (M USD)
Table 96. Middle East and Africa Remdesivir (COVID-19) Consumption Forecast by Country (2025-2030) & (Units)
Table 97. Middle East and Africa Remdesivir (COVID-19) Market Size Forecast by Country (2025-2030) & (M USD)
Table 98. Global Remdesivir (COVID-19) Sales Forecast by Type (2025-2030) & (Kilotons)
Table 99. Global Remdesivir (COVID-19) Market Size Forecast by Type (2025-2030) & (M USD)
Table 100. Global Remdesivir (COVID-19) Price Forecast by Type (2025-2030) & (USD/Ton)
Table 101. Global Remdesivir (COVID-19) Sales (Kilotons) Forecast by Application (2025-2030)
Table 102. Global Remdesivir (COVID-19) Market Size Forecast by Application (2025-2030) & (M USD)

LIST OF FIGURES

Figure 1. Product Picture of Remdesivir (COVID-19)
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Remdesivir (COVID-19) Market Size (M USD), 2019-2030
Figure 5. Global Remdesivir (COVID-19) Market Size (M USD) (2019-2030)
Figure 6. Global Remdesivir (COVID-19) Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Remdesivir (COVID-19) Market Size by Country (M USD)
Figure 11. Remdesivir (COVID-19) Sales Share by Manufacturers in 2023
Figure 12. Global Remdesivir (COVID-19) Revenue Share by Manufacturers in 2023
Figure 13. Remdesivir (COVID-19) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Remdesivir (COVID-19) Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Remdesivir (COVID-19) Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Remdesivir (COVID-19) Market Share by Type
Figure 18. Sales Market Share of Remdesivir (COVID-19) by Type (2019-2024)
Figure 19. Sales Market Share of Remdesivir (COVID-19) by Type in 2023
Figure 20. Market Size Share of Remdesivir (COVID-19) by Type (2019-2024)
Figure 21. Market Size Market Share of Remdesivir (COVID-19) by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Remdesivir (COVID-19) Market Share by Application
Figure 24. Global Remdesivir (COVID-19) Sales Market Share by Application (2019-2024)
Figure 25. Global Remdesivir (COVID-19) Sales Market Share by Application in 2023
Figure 26. Global Remdesivir (COVID-19) Market Share by Application (2019-2024)
Figure 27. Global Remdesivir (COVID-19) Market Share by Application in 2023
Figure 28. Global Remdesivir (COVID-19) Sales Growth Rate by Application (2019-2024)
Figure 29. Global Remdesivir (COVID-19) Sales Market Share by Region (2019-2024)
Figure 30. North America Remdesivir (COVID-19) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America Remdesivir (COVID-19) Sales Market Share by Country in 2023
Figure 32. U.S. Remdesivir (COVID-19) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada Remdesivir (COVID-19) Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico Remdesivir (COVID-19) Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Remdesivir (COVID-19) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe Remdesivir (COVID-19) Sales Market Share by Country in 2023
Figure 37. Germany Remdesivir (COVID-19) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France Remdesivir (COVID-19) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. Remdesivir (COVID-19) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy Remdesivir (COVID-19) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia Remdesivir (COVID-19) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific Remdesivir (COVID-19) Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Remdesivir (COVID-19) Sales Market Share by Region in 2023
Figure 44. China Remdesivir (COVID-19) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan Remdesivir (COVID-19) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea Remdesivir (COVID-19) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India Remdesivir (COVID-19) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia Remdesivir (COVID-19) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America Remdesivir (COVID-19) Sales and Growth Rate (Kilotons)
Figure 50. South America Remdesivir (COVID-19) Sales Market Share by Country in 2023
Figure 51. Brazil Remdesivir (COVID-19) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina Remdesivir (COVID-19) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia Remdesivir (COVID-19) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa Remdesivir (COVID-19) Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Remdesivir (COVID-19) Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Remdesivir (COVID-19) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE Remdesivir (COVID-19) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt Remdesivir (COVID-19) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria Remdesivir (COVID-19) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa Remdesivir (COVID-19) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global Remdesivir (COVID-19) Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Remdesivir (COVID-19) Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Remdesivir (COVID-19) Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Remdesivir (COVID-19) Market Share Forecast by Type (2025-2030)
Figure 65. Global Remdesivir (COVID-19) Sales Forecast by Application (2025-2030)
Figure 66. Global Remdesivir (COVID-19) Market Share Forecast by Application (2025-2030)


More Publications